WElkins has announced it received FDA clearance for a new temperature management system, according to a news release.
The EMT/ICU system is designed to provide caregivers with a non-invasive means of reducing and controlling patient temperature across the continuum of care, according to the company. The system includes a lightweight, portable cooling unit for pre-hospital induction of therapeutic cooling.
WElkins plans to launch the system in the United States immediately and expand to global markets early next year.
"We are very pleased to receive market clearance for the EMT/ICU system, which is the first in a series of new microenvironment cooling products WElkins will be introducing over the next year to our civilian and military clients," said Christopher Blodgett, chief operating officer of Welkins, in the release. "With these devices, WElkins is introducing a new standard in patient temperature management—one that extends active cooling technology to the pre-hospital setting for those critical moments after an injury, in the field and during transit, all the way through to the ICU and recovery. Therapeutic hypothermia has the potential to save lives and limit long-lasting neurological damage, so we are eager to see the EMT/ICU system to market and fulfill WElkins' mission to transform human survival and quality life."
WElkins is headquartered in Roseville, Calif.